Arama

EISSN 2475-0581

IMPACT FACTOR: 0.7 INDEXED IN WEB OF SCIENCE

Psychiatry and Clinical Psychopharmacology

PDF

HIGHLY CITED ARTICLES

The Effect of COVID-19 Pandemic on Psychosomatic Complaints and Investigation of The Mediating Role of Intolerance to Uncertainty, Biological Rhythm Changes and Perceived COVID-19 Threat in this Relationship: A Web-Based Community Survey

by Gıca et al.

COVID-19 Vaccine Hesitancy and Its Relationship With Illness Risk Perceptions, Affect, Worry, and Public Trust: An Online Serial Cross-Sectional Survey From Turkey

by Kucukkarapinar et al.

Evaluation of the Psychiatric Research Output From Turkey Via Web of Science Database: A Bibliometric Analysis

by Topal et al.

High Doses of Second-Generation Long-Acting Antipsychotics in the Treatment of Patients with Severe Resistant Schizophrenia: A Six-Year Mirror-Image Study

by Fernandez- Miranda et al.

Video/Computer Game Addiction Among University Students in Ghana: Prevalence, Correlates and Effects of Some Demographic Factors

by Miezah et al.

Burnout, Job Satisfaction, and Psychological Symptoms Among Emergency Physicians During COVID-19 Outbreak: A Cross-Sectional Study

by Bahadırlı and Sağaltıcı.

Parental Attachment and the Theory of Mind Abilities as Predictors of Internet Addiction in Turkish Adolescents

by Akdeniz et al.

Investigating the Impact of the ECT on Thiol-Disulphide Homeostasis in Depressive Disorders

by Atagün et al.

Comparison of Drugs Prescribed by Psychiatrists and Child/Adolescent Psychiatrists

by Aydin et al.

Adaptation of Internet Gaming Cognition Scale to Turkish: Reliability and Validity Study

by Cakiroglu and Soylu.

All Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 33 results

Ranking

Release Date Sort Sort Article Type

Atomoxetine-Induced Mania in a 6-year-old Child with Autism Spectrum Disorder

Yasar Tanir, Gaye Turkmen

( Psychiatry and Clinical Psychopharmacology 2020; 30: 464-466) DOI: 10.5455/PCP.20201009072139

Abstract Full Text ( PDF) Related Articles

Insignificant Effects of Atomoxetine on Thyroid Functions in Children and Adolescents with Attention Deficit and Hyperactivity Disorder in Short Term

Canan Tanidir, Ibrahim Tanidir, Kayhan Bahali, Hatice Gunes, Hilal Adaletli, Erkut Ozturk, Tolga Unuvar, Ozden Uner

( Psychiatry and Clinical Psychopharmacology 2016; 26: 58-63) DOI: 10.5455/bcp.20150505104526

Abstract Full Text ( PDF) Related Articles

Attention Deficit Hyperactivity Disorder Treatment Practice in Turkey

Ozgur Oner, Hakan Turkcapar, Fatma Isli, Hasan Karadag, Akif Akbulat, Ali Basci, Mesil Aksoy, Cem Seckin, Ali Alkan

( Psychiatry and Clinical Psychopharmacology 2016; 26: 265-272) DOI: 10.5455/bcp.20151202103706

Abstract Full Text ( PDF) Related Articles

Atomoxetine-Induced Mania in a 6-year-old Child with Autism Spectrum Disorder

Insignificant Effects of Atomoxetine on Thyroid Functions in Children and Adolescents with Attention Deficit and Hyperactivity Disorder in Short Term

Attention Deficit Hyperactivity Disorder Treatment Practice in Turkey

Acute Urinary Retention Associated with Increased Dose of Atomoxetine in a Child: A Case Report

Should immediate release methylphenidate be the treatment of choice for initiation of ADHD treatment?

Probable emergence of symptoms of trichotillomania by atomoxetine: a case report

The effects of atomoxetine on weight, height, and body mass index in Turkish children and adolescents with attention deficit hyperactivity disorder

Maintenance of effect in Attention Deficit Hyperactivity Disorder: what do placebo-controlled randomized withdrawal studies of atomoxetine and stimulants tell us?

Improving effect of atomoxetine and reboxetine on memory in passive avoidance task

Atomoxetine induced suicidal ideation: case report

Atomoxetine use in Attention deficit hyperactivity disorder and comorbid tic disorder in PANDAS: two case reports

Combined methylphenidate and atomoxetine therapy in attention deficit hyperactivity disorder; a retrospective study

Atomoxetine-induced dose-dependent bruxism in a child patient

What is the effect of atomoxetine on epilepsy in a boy with attention deficit-hyperactivity disorder?

Treatment choice in association of attention deficit-hyperactivity disorder with Williams and Moebius Syndromes: case reports

Effects of atomoxetine on depression and anxiety symptoms in children with attention deficit-hyperactivity disorder: preliminary findings of a prospective, open-label study

Usage of atomoxetine for encopresis and attention deficit-hyperactivity disorder

Leukopenia due to atomoxetine use: a case report

Motor tics due to atomoxetine use: a case report

Atomoxetine-related hair loss in a teenager: a case report

Recent advances in the psychopharmacology of attention deficit hyperactivity disorder

Psychopharmacology Treatment of skin picking behavior with atomoxetine: a case with corpus callosum agenesis and ADHD

Psychopharmacology Angioedema induced by atomoxetine: a case report

Childhood and adolescence disorders Treatment with atomoxetine: a case with Williams syndrome

Childhood and adolescence disorders Mydriasis after initiating therapy with atomoxetine in a boy with juvenile osteopetrosis: a case report

Psychopharmacology Atomoxetine induced hypomania-like symptoms in a pre-adolescent patient

Childhood and adolescence disorders Pre-treatment and post-treatment Tc-99m TRODAT-1 brain spect findings in three patients with attention deficit and hyperactivity disorder, who were treated by 2-month- atomoxetine treatment

Psychopharmacology Atomoxetine-induced bruxism

Psychopharmacology Atomoxetine-induced mydriasis in a child

Childhood and adolescence disorders Treatment of children with autism spectrum disorders and co-existing attention deficit hyperactivity disorder, with atomoxetine: a retrospective study

Psychopharmacology Atomoxetine and methylphenidate for the treatment of attention deficit hyperactivity disorder: a six-month follow-up study

Atomoxetine for the treatment of ADHD in young adults with an assessment of associated functional outcomes

Treatment compliance in children and adolescents initiated on attention deficit/ hyperactivity disorder (ADHD) medication in clinical practice (COMPLY)